Expression of programmed death-ligand 1 and EGFR on circulating tumour cells in advanced lung cancer patients

被引：0
|
作者：
Khandare, J. [1 ]
Aland, G. [1 ]
Garbhe, M. [2 ]
Gosavi, S. [2 ]
Khutale, G. [3 ]
Patil, M. [2 ]
Tulpule, V. [2 ]
Lokhande, P. [2 ]
Ashturkar, A. [2 ]
Jadhav, V. [2 ]
Vasudevan, A. [2 ]
Jayant, S. [2 ]
Bharde, A. [4 ]
机构：
[1] Actorius Innovat & Res, CTC, Pune, India
[2] Actorius Innovat & Res USA & India, CTC, Pune, India
[3] OneCell Dx, CTC, Pune, India
[4] OneCell Diagnost India Pvt Ltd, CTC, Pune, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2897
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173P
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [1] Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer
    Haratake, Naoki
    Toyokawa, Gouji
    Takada, Kazuki
    Kozuma, Yuka
    Matsubara, Taichi
    Takamori, Shinkichi
    Akamine, Takaki
    Katsura, Masakazu
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Maehara, Yoshihiko
    ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 448 - 454
  • [2] Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation
    Osoegawa, Atsushi
    Abe, Miyuki
    Takumi, Yohei
    Hashimoto, Takafumi
    Karashima, Takashi
    Miyawaki, Michiyo
    Sugio, Kenji
    THORACIC CANCER, 2023, 14 (24) : 2467 - 2472
  • [3] Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression
    Park, H-Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S25 - S25
  • [4] Heterogeneity of programmed death-ligand 1 expression in multifocal lung cancer
    Mansfield, A. S.
    Murphy, S.
    Peikert, T.
    Yi, J.
    Vasmatzis, G.
    Wigle, D.
    Aubry, M. C.
    LUNG CANCER, 2016, 91 : S25 - S26
  • [5] Heterogeneity of programmed cell death-ligand 1 expression in lung cancer
    Mansfield, Aaron
    Murphy, Stephen
    Peikert, Tobias
    Vasmatzis, George
    Wigle, Dennis
    Aubry, Marie Christine
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S31 - S32
  • [6] Clinical Characteristics of Korean Lung Cancer Patients with Programmed Death-Ligand 1 Expression
    Oh, I.
    Park, H.
    Park, C.
    Kim, Y.
    Song, S.
    Kim, S.
    Choi, Y. D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S896 - S897
  • [7] Programmed death-ligand 1 expression in rectal cancer
    Jomrich, G.
    Silberhumer, G. R.
    Marian, B.
    Beer, A.
    Muellauer, L.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2016, 48 (06): : 352 - 356
  • [8] Programmed death-ligand 1 expression in rectal cancer
    G. Jomrich
    G. R. Silberhumer
    B. Marian
    A. Beer
    L. Müllauer
    European Surgery, 2016, 48 : 352 - 356
  • [9] The expression of programmed death-ligand 1 in patients with invasive breast cancer
    Meng, Yi
    Wu, Hongyan
    Yao, Yongzhong
    Li, Rong
    GLAND SURGERY, 2020, 9 (06) : 2106 - 2115
  • [10] Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer
    Yeh, Yi-Chen
    Ma, Hsiu-Hsun
    Chu, Ping-Yuan
    Ho, Hsiang-Ling
    Chou, Teh-Ying
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07):
12345